{
    "2018-10-16": [
        [
            {
                "time": "",
                "original_text": "9月市场小幅上行，为何私募调研次数环比巨减？这只个股是最爱！",
                "features": {
                    "keywords": [
                        "9月",
                        "市场",
                        "上行",
                        "私募",
                        "调研",
                        "个股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗界华为今日上市冲破800亿 它能成为创业板第一吗",
                "features": {
                    "keywords": [
                        "医疗",
                        "华为",
                        "上市",
                        "800亿",
                        "创业板"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]乐普医疗(300003)：业绩高速增长 符合预期",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "买入评级",
                        "业绩",
                        "增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]乐普医疗(300003)：扣非利润略超预期 器械快速增长 药品加速放量",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "买入评级",
                        "扣非利润",
                        "器械",
                        "药品",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "9月百亿私募青睐电子和医药 重阳高毅星石调研热情高",
                "features": {
                    "keywords": [
                        "9月",
                        "私募",
                        "电子",
                        "医药",
                        "调研"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "电子",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗（300003）三季报业绩快报点评：业绩持续高增长，期待可降解支架获批",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "三季报",
                        "业绩",
                        "增长",
                        "可降解支架",
                        "获批"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：17种抗癌药纳入医保目录 创新药研发长期享受政策红利",
                "features": {
                    "keywords": [
                        "医药生物",
                        "抗癌药",
                        "医保目录",
                        "创新药",
                        "政策红利"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "16日公告透露利好 19只个股有望爆发",
                "features": {
                    "keywords": [
                        "公告",
                        "利好",
                        "个股",
                        "爆发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "三季报行业展望之（二）医药生物：逾七成五公司三季报预喜",
                "features": {
                    "keywords": [
                        "三季报",
                        "医药生物",
                        "预喜"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}